PeptideStack
5.2kquestions
20kanswers
220users

What does a purity figure on a JEEP report change about how I read it?

Asked 6 Feb 2026Modified 2 months agoViewed 9.7k times
5

What I am working with: purity figure · JEEP.

I would like help reading this properly rather than being told what conclusion to reach.

I have the full report including the method section, so I can quote specifics if that helps.

What would I need in addition before this supported a decision?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
shareeditfollowflag
EH
askedeighty_six_hours16k276 Feb 2026
6Confirming from the other direction: I did the wrong thing and got exactly the predicted outcome. – k_szabo 7 months ago
5Is there a reason to prefer the second method over the first, other than cost? – esben_lykke 5 months ago
add a comment

5 Answers

Sorted by votes
40

More usefully, what makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.

Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.

The underlying point is that a purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.

Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.

The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
RT
answeredrune_thoresen14k189 Apr 2026
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
26

It helps to be literal here: before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.

A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.

Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
DH
answeredDr_Jonas_Halvorsen41k3821 Apr 2026
7Good answer, but the confidence interval in the cited trial is wider than implied. – Dr_Tomas_Kral 2 months ago
add a comment
21

Stated carefully, the most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.

The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.

The underlying point is that the laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
RS
answeredruaidhri_o_shea51k382 May 2026
For what it is worth, my own result was within half a per cent of this. – fib4_reader 7 months ago
Any reason this would differ for a longer peptide? – Dr_Malik_Osei 5 months ago
add a comment
17

The underlying point is that a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.

The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.

The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
UM
answeredu100_marks38k3813 May 2026
The distinction between purity and content cannot be repeated often enough here. – kirsi_lahtinen 33 days ago
add a comment
12

The certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.

Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.

Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.

Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
TW
answeredtare_weight47k3824 May 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.